Bile acid nephropathy induced by anabolic steroids: A case report and review of the literature

Bile acid nephropathy also known as cholemic nephropathy is a rare and overlooked form of acute kidney injury that occurs in the setting of severe hyperbilirubinemia. The exact etiology remains unknown, and there is a lack of treatment guidelines for this clinical condition. Anabolic steroids are known to cause hepatoxicity occasionally leading to acute kidney injury. We report the case of a 27-year-old male patient who developed bile acid nephropathy as a result of severe hyperbilirubinemia secondary to anabolic steroids-induced liver injury. He was conservatively managed. We review the current literature touching on the etiology, pathophysiology, diagnosis, and management of bile acid nephropathy in an attempt to shed light on this clinical condition, which may present as a diagnostic and therapeutic challenge.

[1]  S. Koubar,et al.  Bile cast nephropathy: when the kidneys turn yellow , 2020, Renal Replacement Therapy.

[2]  J. Desemone,et al.  Severe cholestatic hyperbilirubinaemia secondary to thyrotoxicosis complicated with bile cast nephropathy treated with plasma exchange and haemodialysis , 2019, BMJ Case Reports.

[3]  M. Dickenmann,et al.  Bile Cast Nephropathy: The Unknown Dangers of Online Shopping , 2018, Case Reports in Nephrology and Dialysis.

[4]  M. Praga Terente,et al.  Bile cast nephropathy associated with severe liver dysfunction caused by anabolic steroids. , 2018, Nefrología.

[5]  Christelle El Khoury,et al.  Severe Cholestasis and Bile Cast Nephropathy Induced by Anabolic Steroids Successfully Treated with Plasma Exchange , 2017, Case reports in medicine.

[6]  M. Kumar,et al.  Bile Cast Nephropathy in Patients with Acute Kidney Injury Due to Hepatorenal Syndrome: A Postmortem Kidney Biopsy Study , 2017, Journal of clinical and translational hepatology.

[7]  J. Aronson,et al.  Bile Cast Nephropathy in Cirrhotic Patients: Effects of Chronic Hyperbilirubinemia , 2017, American journal of clinical pathology.

[8]  J. Aniort,et al.  Bile Cast Nephropathy Caused by Obstructive Cholestasis. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  S. Dhillon,et al.  Bile cast nephropathy: A case report and review of the literature. , 2016, World journal of gastroenterology.

[10]  J. Bacchetta,et al.  Efficacy of extracorporeal albumin dialysis for acute kidney injury due to cholestatic jaundice nephrotoxicity , 2016, BMJ Case Reports.

[11]  S. Nasr,et al.  Acute bile nephropathy secondary to anabolic steroids. , 2016, Clinical Nephrology.

[12]  R. Rahimi,et al.  Severe Cholestasis and Bile Acid Nephropathy From Anabolic Steroids Successfully Treated With Plasmapheresis , 2016, ACG case reports journal.

[13]  M. Bauer,et al.  Molecular adsorbent recirculating system and single-pass albumin dialysis in liver failure – a prospective, randomised crossover study , 2015, Critical Care.

[14]  S. Tabatabaee,et al.  Bile cast nephropathy due to cholestatic jaundice after using stanozolol in 2 amateur bodybuilders. , 2015, Iranian Journal of Kidney Diseases.

[15]  B. Jaber,et al.  Albumin Dialysis for Liver Failure: A Systematic Review. , 2015, Advances in chronic kidney disease.

[16]  X. Gu,et al.  Bile cast nephropathy: An often forgotten diagnosis , 2015, Hemodialysis international. International Symposium on Home Hemodialysis.

[17]  M. Perazella,et al.  Bile acid nephropathy in a bodybuilder abusing an anabolic androgenic steroid. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  Z. Ackerman,et al.  Bile cast nephropathy. , 2014, Kidney international.

[19]  D. Samuel,et al.  Albumin Dialysis With a Noncell Artificial Liver Support Device in Patients With Acute Liver Failure , 2013, Annals of Internal Medicine.

[20]  F. Salem,et al.  Bile cast nephropathy is a common pathologic finding for kidney injury associated with severe liver dysfunction. , 2013, Kidney international.

[21]  M. Çetin,et al.  Treatment with plasma exchange may serve benefical effect in patients with severe hyperbilirubinemia: a single center experience. , 2013, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[22]  Antonio Gasbarrini,et al.  Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute‐on‐chronic liver failure: The RELIEF trial , 2013, Hepatology.

[23]  M. Oppert,et al.  Artificial extracorporeal liver support therapy in patients with severe liver failure , 2011, Expert review of gastroenterology & hepatology.

[24]  J. D. de Fijter,et al.  A case of mononucleosis infectiosa presenting with cholemic nephrosis , 2011, NDT plus.

[25]  P. Komolmit,et al.  Effective bilirubin reduction by single-pass albumin dialysis in liver failure. , 2009, Artificial organs.

[26]  R. Deulofeu,et al.  Albumin dialysis improves hepatic encephalopathy and decreases circulating phenolic aromatic amino acids in patients with alcoholic hepatitis and severe liver failure , 2009, Critical care.

[27]  Brendan McGuire,et al.  Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis , 2007, Hepatology.

[28]  F. Nevens,et al.  Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure , 2006, Critical care.

[29]  Roger Williams,et al.  Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis. , 2005, Journal of hepatology.

[30]  R. Standish,et al.  Benign recurrent intrahepatic cholestasis with secondary renal impairment treated with extracorporeal albumin dialysis , 2005, European journal of gastroenterology & hepatology.

[31]  P. Kimmel,et al.  Modification of continuous venovenous hemodiafiltration with single-pass albumin dialysate allows for removal of serum bilirubin. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[32]  R. Bañares,et al.  Hepatic and systemic haemodynamic changes after MARS in patients with acute on chronic liver failure , 2003, Liver international : official journal of the International Association for the Study of the Liver.

[33]  T. Risler,et al.  Improvement of hepatorenal syndrome with extracorporeal albumin dialysis mars: Results of a prospective, randomized, controlled clinical trial , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.